Biotech

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Amyris Inc. (NASDAQ:AMRS) reported that Temasek Holdings (private) Ltd. has picked up 66,254,624 of common stock as of 2016-12-15. The acquisition brings the aggregate amount owned by Temasek Holdings (private) Ltd. to a total of...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Dexcom Inc (NASDAQ:DXCM) reported that Brown Advisory Inc. has picked up 93,780 of common stock as of 2016-12-09. The acquisition brings the aggregate amount owned by Brown Advisory Inc. to a total of 93,780  representing...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Axogen Inc. (NASDAQ:AXGN) reported that  Flynn James E has picked up 1,838,225 of common stock as of 2016-12-15. The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,838,225 representing...

Easton Pharmaceuticals Inc (OTCMKTS:EAPH) shares fell 13.51% on Wednesday to $0.0160 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.02. The company has a market cap of $16.24 million at 932.73 million shares outstanding. Easton Pharmaceuticals Inc is a development-stage company...

Anavex Life Sciences Corp (OTCMKTS:AVXL) shares were up 12.88% on Monday to $4.88 and flat in after-hours trading. Share prices have been trading in a 52-week range of $2.43 to $8.30. The company has a market cap of $174.27 million at 35.71 million shares outstanding. Anavex Life Sciences Corp is a...